Kezia Catharina Oxe

Dr. Kezia Catharina Oxe

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 September 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
ZGZita Gál
Zita Gál
SBStavroula Boukoura
Stavroula Boukoura
KOKezia Catharina Oxe
Kezia Catharina Oxe
SBSara Badawi
Sara Badawi
BNBlanca Nieto
Blanca Nieto
DPDorthe Helena Payne-Larsen
Dorthe Helena Payne-Larsen
Ribosomal DNA (rDNA) encodes the ribosomal RNA genes and represents an intrinsically unstable genomic region. However, the underlying mechanisms and implications for genome integrity remain elusive. Here, we use Bloom syndrome (BS), a rare genetic disease characterized by DNA repair defects and hyper-unstable rDNA, as a model to investigate the mechanisms leading to rDNA instability. We find that in Bloom helicase (BLM) proficient cells, the homologous recombination (HR) pathway in rDNA resembles that in nuclear chromatin; it is initiated by resection, replication protein A (RPA) loading and BRCA2-dependent RAD51 filament formation. However, BLM deficiency compromises RPA-loading and BRCA1/2 recruitment to rDNA, but not RAD51 accumulation. RAD51 accumulates at rDNA despite depletion of long-range resection nucleases and rDNA damage results in micronuclei when BLM is absent. In summary, our findings indicate that rDNA is permissive to RAD51 accumulation in the absence of BLM, leading to micronucleation and potentially global genomic instability.

11 April 2025 in Science Advances
Verified
Journal Article
Open access
MAMoriah R. Arnold
Moriah R. Arnold
GCGabriel M. Cohn
Gabriel M. Cohn
KOKezia Catharina Oxe
Kezia Catharina Oxe
SESomarr N. Elliott
Somarr N. Elliott
CMCynthia Moore
Cynthia Moore
VUVivek Unni
Vivek Unni
Although an increased risk of the skin cancer melanoma in people with Parkinson’s disease (PD) has been shown in multiple studies, the mechanisms involved are poorly understood, but increased expression of the PD-associated protein alpha-synuclein (αSyn) in melanoma cells may be important. Our previous work suggests that αSyn can facilitate DNA double-strand break (DSB) repair, promoting genomic stability. We now show that αSyn is preferentially enriched within the nucleolus in melanoma, where it colocalizes with DNA damage markers and DSBs. Inducing DSBs specifically within nucleolar ribosomal DNA (rDNA) increases αSyn levels near sites of damage. αSyn knockout increases DNA damage within the nucleolus at baseline, after specific rDNA DSB induction, and prolongs the rate of recovery from this induced damage. αSyn is important downstream of ataxia-telangiectasia–mutated signaling to facilitate MDC1-mediated 53BP1 recruitment to DSBs, reducing micronuclei formation and promoting cellular proliferation, migration, and invasion.

14 January 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
MAMoriah R. Arnold
Moriah R. Arnold
GCGabriel M. Cohn
Gabriel M. Cohn
KOKezia Catharina Oxe
Kezia Catharina Oxe
SESomarr N. Elliott
Somarr N. Elliott
CMCynthia Moore
Cynthia Moore
VUVivek Unni
Vivek Unni
Although an increased risk of the skin cancer melanoma in people with Parkinson’s Disease (PD) has been shown in multiple studies, the mechanisms involved are poorly understood, but increased expression of the PD-associated protein alpha-synuclein (αSyn) in melanoma cells may be important. Our previous work suggests that αSyn can facilitate DNA double-strand break (DSB) repair, promoting genomic stability. We now show that αSyn is preferentially enriched within the nucleolus in the SK-MEL28 melanoma cell line, where it colocalizes with DNA damage markers and DSBs. Inducing DSBs specifically within nucleolar ribosomal DNA (rDNA) increases αSyn levels near sites of damage. αSyn knockout increases DNA damage within the nucleolus at baseline, after specific rDNA DSB induction, and prolongs the rate of recovery from this induced damage. αSyn is important downstream of ATM signaling to facilitate 53BP1 recruitment to DSBs, reducing micronuclei formation and promoting cellular proliferation, migration, and invasion.

18 July 2025 in Cells
Verified
Journal Article
Open access
PDF file
KOKezia Catharina Oxe
Kezia Catharina Oxe
KRKristoffer Staal Rohrberg
Kristoffer Staal Rohrberg
ULUlrik Niels Lassen
Ulrik Niels Lassen
DPDorthe Helena Payne-Larsen
Dorthe Helena Payne-Larsen
The current understanding of cellular protein distribution in clinical samples is limited. This is partially due to the complexity and heterogeneity of tissues combined with the qualitative nature of analysis by immunohistochemistry (IHC). The common use of manual assessment in the clinic is time-consuming and restricts both the complexity of scoring and the scale of patient tissue analysis. This has limited the transfer of biological observations into pathology and their integration into diagnostics. Immunofluorescence (IF) techniques allow detailed and high-throughput investigation of proteins in cell models, but their application to tissues has been hindered by poor antibody penetration, autofluorescence artefacts, and weak signals. With a growing focus on precision medicine, scalable techniques to investigate and analyse proteins are critically important. To address this, we generated a high-throughput ImmunoHistoFluorescence (IHF) approach, applying IF to tissue samples followed by automated acquisition and artificial intelligence (AI)-based analysis of sub-nuclear protein distribution to enable precise investigation of complex protein localization patterns. This advancement offers a method to transfer in vitro findings into human tissues to analyse protein localization patterns in physiologically relevant contexts for improved understanding of disease-driving mechanisms in patients, identification of new biomarkers, and acceleration of translational research.

9 January 2026 in NAR Cancer
Verified
Journal Article
Open access
SGSille Blangstrup Geisler
Sille Blangstrup Geisler
KOKezia Catharina Oxe
Kezia Catharina Oxe
SBStavroula Boukoura
Stavroula Boukoura
EDEkaterina Dulina
Ekaterina Dulina
DPDorthe Helena Payne-Larsen
Dorthe Helena Payne-Larsen
Globally, liver cancer is the sixth most prevalent cancer type and the third leading cause of cancer-related deaths, making the need for improved treatment evident. We conducted a pan-cancer tissue microarray analysis to identify cancer types with upregulated ribosome biogenesis, potentially suitable for treatment with nucleolar-targeting compounds. Our screening identified liver cancer as a potential candidate. Gene expression analysis confirmed upregulation of nucleolar factors facilitating ribosome biogenesis that correlated with poor prognosis. In hepatocellular carcinoma (HCC) cell lines, constituting around 80% of liver cancer cases, we confirmed the upregulation of the nucleolar proteins Treacle, UBF, and Fibrillarin, involved in transcription and processing of ribosomal RNA (rRNA). Measurements of rRNA also confirmed increased nucleolar activity. We treated the HCC cell lines with nucleolar-targeting compounds and observed increased sensitivity in the HCC cell lines. Notably, nucleolar targeting compounds demonstrated a broader therapeutic window than that observed for Sorafenib, a clinically approved targeted therapy. Furthermore, we investigated how nucleolar factors change during HCC stages and found a progressive increase in Treacle and Fibrillarin in advanced stages of HCC. Our results demonstrate aberrant nucleolar activity in HCC and propose targeting ribosome biogenesis as a therapeutic strategy to improve HCC patient outcomes.

26 August 2026 in Research Square
Verified
Preprint
Open access
PDF file
SBStavroula Boukoura
Stavroula Boukoura
KOKezia Catharina Oxe
Kezia Catharina Oxe
EDEkatarina Dulina
Ekatarina Dulina
OQOliver Quevedo
Oliver Quevedo
HXHuixin Xu
Huixin Xu
DPDorthe Helena Payne-Larsen
Dorthe Helena Payne-Larsen
Telomeropathies and ribosomopathies share clinical features such as bone marrow failure, developmental defects and cancer predisposition, suggesting convergent pathogenic mechanisms, yet a broadly unifying molecular basis is lacking. Here we identify the telomeric shelterin component TIN2 as a key regulator of nucleolar function and rDNA stability, thereby linking these disease entities. Using a nucleolar DNA damage response (n-DDR) focused RNAi screen, we show that TIN2 is required for nucleolar DNA damage signalling, rDNA segregation into nucleolar caps, and maintenance of transcription of ribosomal RNA genes (rDNA) and protein synthesis. TIN2 depletion or Dyskeratosis congenita (DC)‑associated TIN2 mutations induce rDNA instability, nucleolar stress and p53‑dependent cell death. Strikingly, loss of additional DC proteins with canonical telomeric roles similarly perturbs the n-DDR. Hyper-PARylation, likely caused by dysregulation of RNAs, drives these defects, as PARP1 knockout restores n-DDR activation in TIN2-deficient cells. Our findings redefine DC as both a telomeric and a nucleolar/rDNA disorder and uncover a potentially targetable PARP‑dependent pathway.